Last update April 10, 2025

C3H8O3

Likely Compatibility

Fairly safe. Mild or unlikely adverse effects. Compatible under certain circumstances. Follow-up recommended. Read Commentary.

Glycerin or glycerol is an osmotic dehydrating agent with hygroscopic and lubricating properties. It increases plasma osmolality, which facilitates the movement of water by osmosis from extravascular spaces into the plasma. It is used orally to reduce intraocular pressure before eye surgery and in the treatment of acute glaucoma. It is also used topically in the eye. Orally or intravenously it is used to reduce intracranial pressure and rectally as a laxative (osmotic and lubricant) in the treatment of constipation. Glycerol is available as an emollient or lubricant in many pharmaceutical preparations (Nice 2000). Topical (ocular, otic, cutaneous), oral, intravenous and rectal administration.

At the date of the last update we found no published data on its excretion in breast milk.

Glycerol or glycerine is a normal constituent of human tissues. It is involved in lipid and galactose synthesis and is metabolised to glucose or glycogen. It is found naturally in breast milk, with higher concentration in colostrum. (Mohammad 2015 and 2014, Jóźwik 2013, Sunehag 2002)

Used as a laxative rectally, it has little or no absorption.

It has been used as a laxative in preterm infants. (Isayama 2019, Dutta 2015, Mena 204)

Oral or intravenous administration is rarely used (extracellular oedema, intracranial hypertension, diagnosis of Ménière's disease). Its short half-life makes it compatible with breastfeeding in these rare cases.

Ophthalmic administration is also compatible.

It has been used in creams and gels to treat nipple soreness and cracks during breastfeeding without clear efficacy (de Barros 2019, Dennis 2014, Morland 2005, Cadwell 2004). It should be thoroughly flushed with water before feeding to prevent the infant from taking it, as its high intestinal absorption could lead to increased plasma osmolarity and dehydration in the infant.

Alternatives

We do not have alternatives for C3H8O3.

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

C3H8O3 is Glycerin in Molecular formula.

Is written in other languages:

C3H8O3 is also known as

Group

C3H8O3 belongs to this group or family:

Tradenames

Main tradenames from several countries containing C3H8O3 in its composition:

Pharmacokinetics

Variable Value Unit
Oral Bioavail. 0 (rectal); 100 (oral) %
Molecular weight 92 daltons
Tmax 1.5 hours
0.5 - 0.75 hours

References

  1. de Barros NR, Dos Santos RS, Miranda MCR, Bolognesi LFC, Borges FA, Schiavon JV, Marques RFC, Herculano RD, Norberto AMQ. Natural latex-glycerol dressing to reduce nipple pain and healing the skin in breastfeeding women. Skin Res Technol. 2019 Jul;25(4):461-468. Abstract
  2. Isayama T. The clinical management and outcomes of extremely preterm infants in Japan: past, present, and future. Transl Pediatr. 2019 Jul;8(3):199-211. Abstract Full text (link to original source)
  3. Dutta S, Singh B, Chessell L, Wilson J, Janes M, McDonald K, Shahid S, Gardner VA, Hjartarson A, Purcha M, Watson J, de Boer C, Gaal B, Fusch C. Guidelines for feeding very low birth weight infants. Nutrients. 2015 Abstract
  4. Mohammad MA, Maningat P, Sunehag AL, Haymond MW. Precursors of hexoneogenesis within the human mammary gland. Am J Physiol Endocrinol Metab. 2015 Abstract
  5. Mena N P, León Del P J, Sandino P D, Ralmolfo B P, Sabatelli D, Llanos M A, Milet L B. [Meconium evacuation to improve feeding tolerance in very low birth weight preterm infants (Emita Protocol)]. Rev Chil Pediatr. 2014 Abstract
  6. Dennis CL, Jackson K, Watson J. Interventions for treating painful nipples among breastfeeding women. Cochrane Database Syst Rev. 2014 Dec 15;(12):CD007366. Abstract
  7. Mohammad MA, Sunehag AL, Haymond MW. De novo synthesis of milk triglycerides in humans. Am J Physiol Endocrinol Metab. 2014 Abstract
  8. Jóźwik M, Jóźwik M, Teng C, Jóźwik M, Battaglia FC. Human breast milk sugars and polyols over the first 10 puerperium days. Am J Hum Biol. 2013 Abstract
  9. Morland-Schultz K, Hill PD. Prevention of and therapies for nipple pain: a systematic review. J Obstet Gynecol Neonatal Nurs. 2005 Jul-Aug;34(4):428-37. Review. Abstract
  10. Cadwell K, Turner-Maffei C, Blair A, Brimdyr K, Maja McInerney Z. Pain reduction and treatment of sore nipples in nursing mothers. J Perinat Educ. 2004 Abstract
  11. Sunehag AL, Louie K, Bier JL, Tigas S, Haymond MW. Hexoneogenesis in the human breast during lactation. J Clin Endocrinol Metab. 2002 Abstract
  12. Nice FJ, Snyder JL, Kotansky BC. Breastfeeding and over-the-counter medications. J Hum Lact. 2000 Nov;16(4):319-31. Review. Erratum in: J Hum Lact 2001 Feb;17(1):90. Abstract

Total visits

4,596

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by La Liga de la Leche, España of Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM